Cargando…
Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles
Pharmacological agents suggested for infarct size limitation have serious side effects when used at cardioprotective doses which hinders their translation into clinical practice. The solution to the problem might be direct delivery of cardioprotective drugs into ischemic-reperfused myocardium. In th...
Autores principales: | Galagudza, Michael, Korolev, Dmitry, Postnov, Viktor, Naumisheva, Elena, Grigorova, Yulia, Uskov, Ivan, Shlyakhto, Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356166/ https://www.ncbi.nlm.nih.gov/pubmed/22619519 http://dx.doi.org/10.2147/IJN.S29511 |
Ejemplares similares
-
Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity
por: Galagudza, Michael M, et al.
Publicado: (2010) -
Fluorescently Labeled Gadolinium Ferrate/Trigadolinium Pentairon(III) Oxide Nanoparticles: Synthesis, Characterization, In Vivo Biodistribution, and Application for Visualization of Myocardial Ischemia–Reperfusion Injury
por: Korolev, Dmitry V., et al.
Publicado: (2022) -
New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery
por: Kurapeev, Dmitry I, et al.
Publicado: (2015) -
Theranostic Platforms Based on Silica and Magnetic Nanoparticles Containing Quinacrine, Chitosan, Fluorophores, and Quantum Dots
por: Korolev, Dmitry V., et al.
Publicado: (2022) -
In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles
por: Ivanov, Sergey, et al.
Publicado: (2012)